ArticleHaematologica2014

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III).

Arnaud Jaccard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.